4.5 Article

Synthesis and X-ray structure of platinum(II), palladium(II) and copper(II) complexes with pyridine-pyrazole ligands: Influence of ligands' structure on cytotoxic activity

Journal

POLYHEDRON
Volume 28, Issue 3, Pages 637-645

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.poly.2008.12.013

Keywords

Synthesis; X-ray structure; Cytotoxic effect; Pyrazole ligands; Platinum(II), Palladium(II), Copper(II)) complexes; 9-Methylguanine

Funding

  1. Medical University of Lodz [502-13-629]
  2. DAAD for fellowship [A/07/01244]
  3. Department of Pharmaceutical Biochemistry at Medical University of Lodz [503-3015-2]

Ask authors/readers for more resources

The new pyrazole ligand 5-(2-hydroxyphenyl)-3-methyl-1-(2-pyridylo)-1H-pyrazole-4-phosphonic acid dimethyl ester (2a) has been used to obtain a series of platinum(II), palladium(II) and copper(II) complexes (3a-7a) as potential anticancer compounds. The molecular structures of the platinum(II) and copper(II) complexes 3a and 6a have been determined by X-ray crystallography. The cytotoxicity of the phosphonic ligand 2a and its carboxylic analog 2b as well as their complexes has been evaluated on leukemia and melanoma cell lines. Copper(II) complexes were found to be more efficient in the induction of melanoma cell death than the platinum(II) or palladium(H) complexes. Cytotoxic effectiveness of compound 7b against melanoma WM-115 cells was two times better than that of cisplatin. The reaction of compound 5b with 9-methylguanine has been studied. (C) 2008 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available